Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis loses latest bid to block generic version of blockbuster heart drug
Reuters
Thu, 10/17/24 - 09:26 am
Tags:
Novartis, generics, Entresto, legal
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
Motley Fool
Thu, 10/17/24 - 09:24 am
Tags:
Novartis, GLP-1 agonists, obesity, weight loss
Novartis terminating midphase SMURF1 trial
Fierce Biotech
Mon, 10/14/24 - 10:19 am
Tags:
Novartis, clinical trials, IPF, LTP001
Novartis inks $1B-plus biobucks deal with Flagship's Generate
Fierce Biotech
Tue, 09/24/24 - 11:41 am
Tags:
Novartis, Generate Biomedicines, protein therapeutics
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
CNBC
Thu, 09/19/24 - 11:13 am
Tags:
Novartis, Pharma CEOs, weight loss, obesity, Vas Narasimhan
Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer
Fierce Pharma
Tue, 09/17/24 - 11:08 pm
Tags:
Novartis, FDA, Eli Lilly, breast cancer, Kisqali
Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction
Clinical Trials Arena
Mon, 09/16/24 - 10:56 am
Tags:
Novartis, Kisqali, breast cancer, clinical trials
ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival
Fierce Pharma
Fri, 09/13/24 - 11:12 am
Tags:
Merck, Welireg, renal cell carcinoma, Novartis, Afinitor, ESMO, clinical trials
Novartis ignites new stage of Voyager pact with $15M capsid deal
Fierce Biotech
Thu, 09/5/24 - 11:28 am
Tags:
Novartis, Voyager Therapeutics, capsids, gene therapy
Novartis builds out radiopharma production with expansion, new factory
BioPharma Dive
Wed, 09/4/24 - 10:44 pm
Tags:
Novartis, radiopharmaceuticals, Indianapolis, California, cancer
Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
Tags:
protein degradation, Arvinas, Merck KGaA, Sanofi, Pfizer, Novartis
Novartis and Genentech’s Xolair is rising rapidly on TV
Medical Marketing and Media
Thu, 08/29/24 - 06:11 pm
Tags:
Novartis, Genentech, Xolair, television ads
Novartis taps Lindy to turn biologic drugs into at-home injectables, puts nearly $1B on the line
Fierce Pharma
Wed, 08/28/24 - 11:46 am
Tags:
Novartis, Lindy Biosciences, drug delivery
Novartis builds case for Leqvio with monotherapy data
Pharmaphorum
Wed, 08/28/24 - 11:29 am
Tags:
Novartis, Leqvio, cholesterol, clinical trials
Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats
Investors Business Daily
Mon, 08/26/24 - 11:11 am
Tags:
Galapagos, CAR-T, FDA, non-Hodgkin lymphoma, Gilead Sciences, Novartis
Novartis receives binding offer from Siemens Healthineers for molecular imaging business
Reuters
Sun, 08/25/24 - 11:02 pm
Tags:
Novartis, M&A, Siemens Healthineers, molecular imaging
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Fierce Biotech
Thu, 08/22/24 - 11:18 am
Tags:
Novartis, Chinook Therapeutics, kidney disease, venture capital, Versant Ventures
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Tags:
Medicare, drug pricing, Inflation Reduction Act, JNJ, Xarelto, Imbruvica, Stelara, Bristol Myers Squibb, Eliquis, Eli Lilly, Jardiance, Merck, Januvia, Amgen, Enbrel, AstraZeneca, Farxiga, Novo Nordisk, Fiasp, Novartis, Entresto
Novartis loses initial bid to block generic of best-selling heart drug
Reuters
Mon, 08/12/24 - 05:57 pm
Tags:
Novartis, legal, MSN Pharmaceuticals, Entresto, heart failure, generics
Novartis' Complement Inhibitor Fabhalta Approved for IgAN
Contract Pharma
Mon, 08/12/24 - 05:52 pm
Tags:
FDA, Novartis, Fabhalta, primary IgA nephropathy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.